Company Filing History:
3 out of 138 
1 out of 109 
1 out of 179 
Years Active: 2015-2025
Title: The Innovative Contributions of Anne Valade
Introduction
Anne Valade is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as positive allosteric modulators of D1 receptors. With a total of 5 patents to her name, Valade's work is paving the way for new treatments in various medical conditions.
Latest Patents
Among her latest patents, Valade has developed a substituted tetrahydroisoquinoline derivative that serves as a D1 positive allosteric modulator. This invention relates to compounds that are beneficial as pharmaceutical agents for treating diseases where D1 receptors play a crucial role. Another notable patent involves tetrahydroisoquinoline derivatives, which are also identified as positive allosteric modulators of D1, further emphasizing their potential in pharmaceutical applications.
Career Highlights
Throughout her career, Anne Valade has worked with notable companies such as UCB Biopharma Sprl and UCB Biopharma Srl. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovation and development.
Collaborations
Valade has collaborated with esteemed colleagues, including Ali Ates and Eric Jnoff. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Anne Valade's innovative work in the pharmaceutical industry highlights her role as a leading inventor. Her contributions, particularly in the area of D1 receptor modulation, are significant for future medical advancements.